BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fletcher MA, Fritzell B. Brief review of the clinical effectiveness of PREVENAR® against otitis media. Vaccine 2007;25:2507-12. [DOI: 10.1016/j.vaccine.2006.09.027] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Corbeel L. What is new in otitis media? Eur J Pediatr 2007;166:511-9. [PMID: 17364173 DOI: 10.1007/s00431-007-0461-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
2 Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, Macnair J, Pujar N, Manger W, Zhang Y, Antonello J, Shiver J, Caulfield M, Heinrichs JH. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine 2011;29:8870-6. [PMID: 21964055 DOI: 10.1016/j.vaccine.2011.09.078] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
3 De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine 2009;27:2877-83. [DOI: 10.1016/j.vaccine.2009.02.102] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
4 Murphy TF. Current and Future Prospects for a Vaccine for Nontypeable Haemophilus influenzae. Curr Infect Dis Rep 2009;11:177-82. [PMID: 19366559 DOI: 10.1007/s11908-009-0027-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
5 Nascimento-Carvalho CM. Pneumococcal conjugate vaccination and otitis media: differences among high-risk and low-risk populations. Expert Rev Vaccines 2009;8:695-8. [PMID: 19485750 DOI: 10.1586/erv.09.42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Wals PD, Carbon M, Sévin E, Deceuninck G, Ouakki M. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 2009;28:e271-5. [PMID: 19710582 DOI: 10.1097/INF.0b013e3181bad212] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
7 Gentile MA, Melchiorre S, Emolo C, Moschioni M, Gianfaldoni C, Pancotto L, Ferlenghi I, Scarselli M, Pansegrau W, Veggi D, Merola M, Cantini F, Ruggiero P, Banci L, Masignani V. Structural and functional characterization of the Streptococcus pneumoniae RrgB pilus backbone D1 domain. J Biol Chem 2011;286:14588-97. [PMID: 21367860 DOI: 10.1074/jbc.M110.202739] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
8 Rose MA, Laurenz M, Sprenger R, Imöhl M, van der Linden M. Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany. Front Med (Lausanne) 2021;8:719481. [PMID: 34589501 DOI: 10.3389/fmed.2021.719481] [Reference Citation Analysis]
9 González-fernández Á, Faro J, Fernández C. Immune responses to polysaccharides: Lessons from humans and mice. Vaccine 2008;26:292-300. [DOI: 10.1016/j.vaccine.2007.11.042] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 4.9] [Reference Citation Analysis]
10 Singh A, Dutta AK. Pneumococcal Vaccines - How Many Serotypes are Enough? Indian J Pediatr 2018;85:47-52. [PMID: 28887787 DOI: 10.1007/s12098-017-2449-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Vickers I, O'Flanagan D, Cafferkey M, Humphreys H. Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes. Eur J Clin Microbiol Infect Dis 2011;30:447-53. [PMID: 21076929 DOI: 10.1007/s10096-010-1108-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
12 Brezinschek HP, Hofstaetter T, Leeb BF, Haindl P, Graninger WB. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate. Curr Opin Rheumatol. 2008;20:295-299. [PMID: 18388521 DOI: 10.1097/bor.0b013e3282ffdeca] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
13 Lee J, Komatsu K, Lee BC, Lim JH, Jono H, Xu H, Kai H, Zhang ZJ, Yan C, Li JD. Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway. J Biol Chem 2012;287:22799-811. [PMID: 22610099 DOI: 10.1074/jbc.M111.337378] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
14 Hau I, Levy C, Caeymaex L, Cohen R. Impact of Pneumococcal Conjugate Vaccines on Microbial Epidemiology and Clinical Outcomes of Acute Otitis Media. Pediatr Drugs 2014;16:1-12. [DOI: 10.1007/s40272-013-0044-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
15 Moschioni M, Emolo C, Biagini M, Maccari S, Pansegrau W, Donati C, Hilleringmann M, Ferlenghi I, Ruggiero P, Sinisi A, Pizza M, Norais N, Barocchi MA, Masignani V. The two variants of the Streptococcus pneumoniae pilus 1 RrgA adhesin retain the same function and elicit cross-protection in vivo. Infect Immun 2010;78:5033-42. [PMID: 20823200 DOI: 10.1128/IAI.00601-10] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
16 Mackenzie GA, Carapetis JR, Leach AJ, Morris PS. Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination. BMC Pediatr 2009;9:14. [PMID: 19228431 DOI: 10.1186/1471-2431-9-14] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
17 Quesnel S, Nguyen M, Pierrot S, Contencin P, Manach Y, Couloigner V. Acute mastoiditis in children: a retrospective study of 188 patients. Int J Pediatr Otorhinolaryngol 2010;74:1388-92. [PMID: 20971514 DOI: 10.1016/j.ijporl.2010.09.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
18 Wouters I, Van Heirstraeten L, Desmet S, Blaizot S, Verhaegen J, Goossens H, Van Damme P, Malhotra-Kumar S, Theeten H; NPcarriage Study Group. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme. Vaccine 2018;36:15-22. [PMID: 29180027 DOI: 10.1016/j.vaccine.2017.11.052] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
19 Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis. 2012;12:207. [PMID: 22954038 DOI: 10.1186/1471-2334-12-207] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 9.7] [Reference Citation Analysis]
20 van der Linden M, Reinert RR. Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis 2010;29:749-54. [PMID: 20432051 DOI: 10.1007/s10096-010-0945-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
21 Imöhl M, Perniciaro S, Busse A, van der Linden M. Bacterial Spectrum of Spontaneously Ruptured Otitis Media in a 7-Year, Longitudinal, Multicenter, Epidemiological Cross-Sectional Study in Germany. Front Med (Lausanne) 2021;8:675225. [PMID: 34095179 DOI: 10.3389/fmed.2021.675225] [Reference Citation Analysis]
22 Fletcher MA, Fritzell B. Pneumococcal conjugate vaccines and otitis media: an appraisal of the clinical trials. Int J Otolaryngol 2012;2012:312935. [PMID: 22701486 DOI: 10.1155/2012/312935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
23 Schraff SA. Contemporary indications for ventilation tube placement. Curr Opin Otolaryngol Head Neck Surg. 2008;16:406-411. [PMID: 18797280 DOI: 10.1097/moo.0b013e3283095046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
24 Dagan R, Pelton S, Bakaletz L, Cohen R. Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis 2016;16:480-92. [PMID: 27036355 DOI: 10.1016/S1473-3099(15)00549-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 35] [Article Influence: 13.8] [Reference Citation Analysis]
25 Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, Gelbmann D, Lundberg U, Senn BM, Schunn M, Habel A, Henriques-Normark B, Ortqvist A, Kalin M, von Gabain A, Nagy E. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 2008;205:117-31. [PMID: 18166586 DOI: 10.1084/jem.20071168] [Cited by in Crossref: 201] [Cited by in F6Publishing: 194] [Article Influence: 13.4] [Reference Citation Analysis]
26 Ansaldi F, Sticchi L, Durando P, Carloni R, Oreste P, Vercelli M, Crovari P, Icardi G. Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy. J Int Med Res 2008;36:1255-60. [PMID: 19094434 DOI: 10.1177/147323000803600612] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
27 De Angelis G, Moschioni M, Muzzi A, Pezzicoli A, Censini S, Delany I, Lo Sapio M, Sinisi A, Donati C, Masignani V, Barocchi MA. The Streptococcus pneumoniae pilus-1 displays a biphasic expression pattern. PLoS One 2011;6:e21269. [PMID: 21731688 DOI: 10.1371/journal.pone.0021269] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
28 Moschioni M, De Angelis G, Harfouche C, Bizzarri E, Filippini S, Mori E, Mancuso G, Doro F, Barocchi MA, Ruggiero P, Masignani V. Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations. Vaccine 2012;30:1349-56. [PMID: 22210141 DOI: 10.1016/j.vaccine.2011.12.080] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
29 van der Linden M, Imöhl M, Busse A, Rose M, Adam D. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr 2015;174:355-64. [PMID: 25169065 DOI: 10.1007/s00431-014-2409-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]